MS Consult

Bladder Complications in MS

Author and Disclosure Information

 

References

Which treatment should you choose? Insurance companies tend to prefer generic, older-generation anticholinergics, but bear in mind that these can cause or contribute to cognitive issues (which many patients with MS already have).3 Another medication, such as mirabegron, may be preferable; it’s less likely than anticholinergics to cause dry mouth, which may help with compliance. Also, be aware that anticholinergics can cause blurred vision, which might lead patients to believe they are having optic neuritis or another MS-related visual change.4

That said, it is possible for patients to have a relapse and a UTI simultaneously. Due to potential adverse effects, it is essential to balance the risks and benefits of steroid therapy. Steroids could worsen an untreated infection and may not be appropriate for the patient’s symptoms or chief complaint.

Addressing bladder symptoms can not only help prevent UTIs but can also improve skin integrity, sleep quality, independence, and overall quality of life. A thorough exam and history-taking can alleviate secondary and tertiary urinary complications, as well as avoid unnecessary use of corticosteroids. -DRB

Denise R. Bruen, MSN, APRN-BC, MSCN
University of Virgina, Charlottesville

Pages

Recommended Reading

NORD Reopens Call for Abstracts for Research Grants
Clinician Reviews
Poster Abstracts Due January 31 for European Conference on Rare Diseases and Orphan Products
Clinician Reviews
Beta Version of ClinicalTrials.gov Website Available for Public Testing
Clinician Reviews
NORD Welcomes Five New Member Organizations
Clinician Reviews
Guthy-Jackson Charitable Foundation Produces New NMO Podcast
Clinician Reviews
New Book Chronicles Advances in Understanding NMO and Provides Blueprint for Other Rare Diseases
Clinician Reviews
Register Now for Adrenal Insufficiency United Conference
Clinician Reviews
Homocystinuria Research Grants Are Available
Clinician Reviews
15th International Symposium on MPS and Related Diseases Is Planned
Clinician Reviews
Collaborative Effort Is Underway to Screen Small Molecules for Therapeutic Potential for NGLY1 Deficiency
Clinician Reviews

Related Articles